Some diabetes meds might lower risk of dementia, Parkinson's
· UPIA specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to filter sugar out of the bloodstream and excrete it in urine, researchers said.
Advertisement